Full AI Image Prompt: Create a clinical safety infographic titled GHK-Cu Safety Considerations by Route. Use a three-column matrix labeled Topical products, Wound-care study context, and Injectable or compounded preparations. Under topical products, include skin irritation, allergic reaction, and formulation sensitivity. Under wound-care study context, include study exclusions, copper or peptide sensitivity, and dressings or adhesives. Under injectable or compounded preparations, include limited human safety data, peptide-related impurities, aggregation risk, and immunogenicity risk. Use a calm medical style, white background, simple icons, and subtle copper-blue accents
Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitors: Are They All the Same
Most current guidelines recommend stopping GLP-1s at least two months before trying to conceive, especially because some of these medications stay in the body for weeks after the last dose
Clinicians are still responsible for making decisions appropriate for each patient
Available to students who are, Acupuncturists, Beauty Therapists Level 3 or equivalent, Body Piercers, Dental Nurses, Dental Hygienists, Doctors, Nurses, Paramedics, Pharmacist, Phlebotomists, Semi Permanent Makeup Practitioners, Microblader or Tattoo Artists
however, they reported that preliminary studies from their laboratory using inhaled NAC did not see any protective effects against DEPs in an in vivo human nasal model [53]